Abstract

The mucilage-secreting desmid, Closterium acerosum, is sensitive to the secretory inhibiting drug, brefeldin A (BFA). After 5 min of treatment with 5 μg ml -1 of BFA, the Golgi body displays the following alterations: the number of cisternae decreases from 12-15 to 6-7; peripheries of cisternae from the same Golgi body often fuse to yield unique profiles; secretory vesicles still emerge from the Golgi body; the cisternal stack dissociates to form irregular masses in the valleys of cytoplasm created by the lobes of the chloroplast. Fluoresbrite bead labelling shows that mucilage production ceases in cells treated with BFA even after only 5 min of treatment. Immunogold labelling using anti-mucilage antibody reveals that mucilage production still occurs in the Golgi body and associated vesicles. Helix pomatia lectin-gold labelling shows that wall synthesis still occurs in BFA-treated Golgi bodies and wall precursors accumulate in the perforate cisternal/vesicular masses seen in the TGN region of the Golgi stack.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.